Literature DB >> 29970401

IgLON5: A case with predominant cerebellar tau deposits and leptomeningeal inflammation.

Florian Schöberl1, Johannes Levin2, Jan Remi2, Nicolina Goldschagg2, Ozan Eren2, Nobuyuki Okamura2, Marcus Unterrainer2, Axel Rominger2, Nathalie Albert2, Matthias Brendel2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29970401     DOI: 10.1212/WNL.0000000000005859

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  7 in total

1.  In response to: The validity of 18F-GE180 as a TSPO imaging agent.

Authors:  Nathalie L Albert; Marcus Unterrainer; Matthias Brendel; Lena Kaiser; Markus Zweckstetter; Paul Cumming; Peter Bartenstein
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-03-02       Impact factor: 9.236

Review 2.  Sleep and neurological autoimmune diseases.

Authors:  Alex Iranzo
Journal:  Neuropsychopharmacology       Date:  2019-07-14       Impact factor: 7.853

3.  Frequency and Characterization of Movement Disorders in Anti-IgLON5 Disease.

Authors:  Carles Gaig; Yaroslau Compta; Anna Heidbreder; Maria J Marti; Maarten J Titulaer; Yvette Crijnen; Birgit Högl; Jan Lewerenz; María Elena Erro; Juan Carlos Garcia-Monco; Pasquale Nigro; Nicola Tambasco; Maja Patalong-Ogiewa; Marcus Erdler; Stefan Macher; Evelyn Berger-Sieczkowski; Romana Höftberger; Christian Geis; Markus Hutterer; Angela Milán-Tomás; Antonio Martin-Bastida; Lydia Lopez Manzanares; Sonia Quintas; Günter U Höglinger; Nora Möhn; Florian Schoeberl; Franziska S Thaler; Gian Maria Asioli; Federica Provini; Giuseppe Plazzi; Koldo Berganzo; Morten Blaabjerg; Norbert Brüggemann; Tarsis Farias; Chen Fei Ng; Caroline Giordana; Alejandro Herrero-San Martín; Lucio Huebra; Katya Kotschet; Herburg Liendl; Teresa Montojo; Carlos Morata; Jesus Perez Perez; Inmaculada Puertas; Thomas Seifert-Held; Caspar Seitz; Mateus Mistieri Simabukuro; Nieves Tellez; Javier Villacieros-Álvarez; Barbara Willekens; Lidia Sabater; Alex Iranzo; Joan Santamaria Cano; Josep Dalmau; Francesc Graus
Journal:  Neurology       Date:  2021-08-11       Impact factor: 11.800

4.  Anti-IgLON5 Disease: A Case With 11-Year Clinical Course and Review of the Literature.

Authors:  Mette Scheller Nissen; Morten Blaabjerg
Journal:  Front Neurol       Date:  2019-10-02       Impact factor: 4.003

5.  Cerebrospinal Fluid Findings in Patients With Autoimmune Encephalitis-A Systematic Analysis.

Authors:  Tetyana Blinder; Jan Lewerenz
Journal:  Front Neurol       Date:  2019-07-25       Impact factor: 4.003

6.  IgLON 5 Antibody Syndrome: Isolated Case of a Patient With Indolent Disease Progression and Unusual MRI Findings.

Authors:  Sihyeong Park; Jonathan Doan; Irfan Sheikh; Ajaz A Sheikh
Journal:  Cureus       Date:  2021-02-17

7.  Ocular Motor Abnormalities in Anti-IgLON5 Disease.

Authors:  Stefan Macher; Ivan Milenkovic; Tobias Zrzavy; Romana Höftberger; Stefan Seidel; Evelyn Berger-Sieczkowski; Thomas Berger; Paulus S Rommer; Gerald Wiest
Journal:  Front Immunol       Date:  2021-09-30       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.